11-108343230-CCTCT-CCT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.8283_8284delTC(p.Gln2762AlafsTer6) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S2761S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 frameshift
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATM | NM_000051.4 | c.8283_8284delTC | p.Gln2762AlafsTer6 | frameshift_variant | Exon 57 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial cancer of breast Pathogenic:2
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
- -
Ataxia-telangiectasia syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln2762Alafs*6) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with ataxia-telangiectasia (PMID: 8845835). ClinVar contains an entry for this variant (Variation ID: 482713). For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.8283_8284delTC pathogenic mutation, located in coding exon 56 of the ATM gene, results from a deletion of two nucleotides at nucleotide positions 8283 to 8284, causing a translational frameshift with a predicted alternate stop codon (p.Q2762Afs*6). This alteration has been reported in numerous individuals with Ataxia-Telangiectasia (Gilad S et al. Hum. Mol. Genet., 1996 Apr;5:433-9; Magliozzi M et al. Dis. Markers, 2006;22:257-64; Perfettini JL et al. PLoS ONE, 2008 Jun;3:e2458) and has been described as a Spanish/Italian founder mutation based on haplotype analysis (Chessa L et al. Ann. Hum. Genet., 2009 Sep;73:532-9; Mitui M et al. Hum. Mutat., 2003 Jul;22:43-50). Of note, this alteration is also designated as 8283delTC in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at